CHICAGO–(BUSINESS WIRE)–physIQ announced today that Raquel C. Bono, M.D., a board-certified trauma surgeon and retired Vice Admiral of the United States Navy Medical Corps, has been selected as a member of the company’s Advisory Board. Dr. Bono retired from the Navy in 2019 as Chief Executive Officer and Director for the […]
Other News
Stacy Enxing Seng Joins the Vesper Medical Board of Directors
Wayne, PA, January 4, 2021 Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced that Stacy Enxing Seng has joined the board of directors effective immediately. An accomplished executive leader, Stacy has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios, […]
Dr. Michael Siropaides Joins Modern Heart & Vascular Institute
Esteemed Board-Certified Cardiologist Michael Siropaides, MD joins Modern Heart and Vascular Institute, bringing 30 years of excellent bedside cardiovascular skills and experience. HOUSTON, Jan. 4, 2021 /PRNewswire/ — Modern Heart and Vascular Institute welcomes Michael Siropaides, MD to the team. Dr. Siropaides has been practicing cardiovascular medicine for thirty-plus years. His energy and passion […]
Matinas BioPharma Announces FDA Conditional Acceptance of LYPDISO™ as the Brand Name for MAT9001
BEDMINSTER, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care in areas of significant unmet medical need, today announced the U.S. Food and Drug Administration (FDA) has conditionally accepted LYPDISO™ as the […]
AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy
Expansion includes adolescent patients, as young as 12 years of age, who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall. MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that […]
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and Structural Heart Procedures SAN CARLOS, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of U.S. Patent No: 10,874, 831 for “Devices and Methods for […]
Teleflex Completes Acquisition of Market Leader in Hemostatic Products
WAYNE, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced today that it has completed the previously announced acquisition of Z-Medica, LLC, an industry-leading manufacturer of hemostatic products. On October 28, 2020, Teleflex announced a definitive agreement to acquire Z-Medica. Under the […]
CARMAT Receives the CE Marking for Its Total Artificial Heart
CE marking allows the company to market its total artificial heart in the EU as a bridge to transplant Virtual press conference scheduled on January 6, 2021 PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an […]
Cytokinetics Regains European Rights to Omecamtiv Mecarbil
Company is Planning Regulatory Interactions in 2021 to Discuss Results of GALACTIC-HF and Expects to Evaluate Strategic Options for Co-Commercialization and Licensing SOUTH SAN FRANCISCO, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) announced that Amgen Inc. (“Amgen”) notified the company that Les Laboratoires Servier and Institut […]
MicroVention, Inc. Files Trade Secret Lawsuit Against Balt USA, LLC
ALISO VIEJO, Calif., Dec. 23, 2020 /PRNewswire/ — MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the filing of a second lawsuit against Balt USA, LLC and four former employees for trade secret misappropriation. This lawsuit follows an earlier patent lawsuit filed against Balt USA in July 2019 that is ongoing. […]



